Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection

Clinical Infectious Diseases

Volumn 51, Issue 2, 2010, Pages 242-247

  Papadopoulos, Antonios I ^a   Ferwerda, Bart ^a   Antoniadou, Anastasia ^b   Sakka, Vissaria ^a   Galani, Lambrini ^a   Kavatha, Dimitra ^a   Panagopoulos, Periklis ^a   Poulakou, Garyphalia ^a   Kanellakopoulou, Kyriaki ^a   Van Der Meer, Jos W M ^a   Giamarellos Bourboulis, Evangelos J ^a   Netea, Mihai G ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; COTRIMOXAZOLE; GLYCINE; ISOLEUCINE; MACROLIDE; PNEUMOCOCCUS VACCINE; PYRROLE DERIVATIVE; THREONINE; TOLL LIKE RECEPTOR 4;

ADULT; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GREECE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SUBSTITUTION; COMPLICATION; DNA SEQUENCE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR GENETICS; RISK; VIROLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SUBSTITUTION; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 4;

EID: 77954723675     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653607     Document Type: Article

References (31)

1. Cohen DE, Walker BD. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection. Clin Infect Dis 2001; 32:1756-1768.
2. Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439-446.
3. Noursadeghi M, Katz DR, Miller RF. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 2006; 6:794-804.
4. Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300:1524-1525.
5. Sanders CM, Cruse JM, Lewis RE. Toll-like receptors, cytokines and HIV-1. Exp Mol Pathol 2008; 84:31-36.
6. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-14.
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
8. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430:257-263.
9. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006; 13:816-825.
10. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998; 282:2085-2088.
11. Netea MG, Van Der Graaf CA, Vonk AG, et al. The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185:1483-1489.
12. Ferwerda B, McCall MB, Alonso S, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 2007; 104:16645-16650.
13. Ferwerda B, McCall MB, Verheijen K, et al. Functional consequences of Toll-like receptor 4 polymorphisms. Mol Med 2008; 14:346-352.
14. Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5:156-164.
15. Pamer EG. TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med 2008; 359:1836-1838.
16. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-191.
17. Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008; 359:1766-1777.
18. Carvalho A, Pasqualotto AC, Pitzurra L, et al. Polymorphisms in Tolllike receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197:618-621.
19. Van der Graaf CA, Netea MG, Morré SA, et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17:29-34.
20. Senthilselvan A, Rennie D, Chénard L, et al. Association of polymorphisms of Toll-like receptor 4 with a reduced prevalence of hay fever and atopy. Ann Allergy Asthma Immunol 2008; 100:463-468.
21. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Tolllike receptor 4 polymorphisms are associated with resistance to legionnaires disease. Proc Natl Acad Sci USA 2005; 102:2487-2489.
22. Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, et al. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr 2008; 49:128-135.
23. Bochud PY, Hersberger M, Taffé P, et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21:441-446.
24. Ferwerda B, Kibiki GS, Netea MG, et al. The Toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 2007; 21:1375-1377.
25. Ancelle-Park R. Expanded European AIDS case definition. Lancet 1993; 341:441.
26. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR Recomm Rep 1992; 41(RR-17):1-19.
27. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Resp Crit Care Med 2006; 174:84-93.
28. Lester RT, Yao XD, Ball TB, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008; 22: 685-694.
29. Báfica A, Scanga CA, Schito M, et al. Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol 2004; 172:7229-7234.
30. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
31. Lester RT, Yao XD, Ball TB, et al. HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers. PLoS One 2009; 4:e5644.